Clinical Trial Update: Efficacy and Safety of Imatinib and Vinorelbine in Patients With Advanced Breast Cancer [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing the efficacy and safety of combining imatinib with vinorelbine in patients with advanced breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Imatinib (imatinib)
• Vinorelbine (Vinorelbine)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Breast Cancer | Phase 4 | Status: COMPLETED